BackgroundCheck.run
Search For

Jing H XiaWinter Garden, FL

Jing Xia Phones & Addresses

Winter Garden, FL   

Orlando, FL   

Altamonte Springs, FL   

1204 60Th St, Brooklyn, NY 11219    718-4357119   

73 Bay 38Th St, Brooklyn, NY 11214    718-9468153   

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: High school graduate or higher

Mentions for Jing H Xia

Career records & work history

Lawyers & Attorneys

Jing Xia Photo 1

Jing Xia, New York NY - Lawyer

Address:
Axinn, Veltrop & Harkrider LLP
114 W 47Th St, New York, NY 10036
212-7282200 (Office)
Licenses:
New York - Currently registered 2011
Education:
Rutgers University School of Law - Newark
Jing Xia Photo 2

Jing Xia, New York NY - Lawyer

Address:
New York, NY
Licenses:
New Jersey - Active 2011

License Records

Jing Xia

Licenses:
License #: 239028778 - Expired
Issued Date: Jul 23, 2012
Expiration Date: Sep 30, 2015
Type: Registered Certified Public Accountant

Resumes & CV records

Resumes

Jing Xia Photo 35

Jing Xia

Industry:
Capital Markets
Skills:
Financial Modeling, Data Analysis, Investment Banking, Financial Statement Analysis, Risk Management, Credit Risk, Analytics, Financial Statement, Financial Analysis, Software, Fixed Income Analysis
Jing Xia Photo 36

Jing Xia

Jing Xia Photo 37

Jing Xia

Location:
United States

Publications & IP owners

Us Patents

Methods Of Preparing Polymers Having Terminal Amine Groups

US Patent:
7868131, Jan 11, 2011
Filed:
Aug 23, 2006
Appl. No.:
11/508507
Inventors:
Hong Zhao - Edison NJ, US
Belen Rubio - Somerset NJ, US
Jing Xia - Warren NJ, US
Assignee:
Enzon Pharmaceuticals, Inc. - Bridgewater NJ
International Classification:
C08G 79/02
C08G 79/08
C08G 73/00
US Classification:
528398, 528 4, 528394, 528422, 528425, 528480, 528487, 528488, 528492, 528495
Abstract:
The present invention is directed to methods of preparing linear polymers such as polyalkylene oxides containing a terminal amine in high purity. One preferred method includes reacting a polyalkylene oxide such as polyethylene glycol containing a terminal azide with a phosphine-based reducing agent such as triphenylphosphine or an alkali metal borohydride reducing agent such as sodium borohydride in a solvent to reflux. The resultant polymer-amines are of sufficient purity so that expensive and time consuming purification steps required for pharmaceutical grade polymers are avoided.

Methods Of Preparing Polymers Having Terminal Amine Groups

US Patent:
2007004, Mar 1, 2007
Filed:
Aug 26, 2005
Appl. No.:
11/212901
Inventors:
Hong Zhao - Edison NJ, US
Belen Rubio - Somerset NJ, US
Jing Xia - Warren NJ, US
International Classification:
C08G 79/02
US Classification:
528398000
Abstract:
The present invention is directed to methods of preparing linear polymers such as polyalkylene oxides containing a terminal amine in high purity. One preferred method includes reacting a polyalkylene oxide such as polyethylene glycol containing a terminal azide with a phosphine-based reducing agent such as triphenylphosphine or an alkali metal borohydride reducing agent such as sodium borohydride in a solvent to reflux. The resultant polymer-amines are of sufficient purity so that expensive and time consuming purification steps required for pharmaceutical grade polymers are avoided.

Methods Of Preparing Polymers Having Terminal Amine Groups

US Patent:
2007004, Mar 1, 2007
Filed:
Dec 1, 2005
Appl. No.:
11/291546
Inventors:
Hong Zhao - Edison NJ, US
Belen Rubio - Somerset NJ, US
Jing Xia - Warren NJ, US
International Classification:
C08G 79/02
US Classification:
528398000
Abstract:
The present invention is directed to methods of preparing linear polymers such as polyalkylene oxides containing a terminal amine in high purity. One preferred method includes reacting a polyalkylene oxide such as polyethylene glycol containing a terminal azide with a phosphine-based reducing agent such as triphenylphosphine or an alkali metal borohydride reducing agent such as sodium borohydride in a solvent to reflux. The resultant polymer-amines are of sufficient purity so that expensive and time consuming purification steps required for pharmaceutical grade polymers are avoided.

Polymeric Conjugates Containing Positively-Charged Moieties

US Patent:
2009020, Aug 13, 2009
Filed:
Mar 12, 2009
Appl. No.:
12/402922
Inventors:
Hong ZHAO - Edison NJ, US
Prasanna REDDY - Somerset NJ, US
Ivan HORAK - West Orange NJ, US
Jing XIA - Warren NJ, US
Assignee:
ENZON PHARMACEUTICALS, INC. - Bridgewater NJ
International Classification:
A61K 47/48
C07C 271/22
C07D 403/14
C07H 21/02
C07K 16/00
A61K 31/27
A61K 31/4025
A61K 38/00
A61K 31/7105
A61K 31/496
A61K 39/395
A61K 38/43
C12N 5/00
US Classification:
4241791, 560148, 548520, 530328, 530300, 536 231, 530327, 544357, 435183, 5303911, 514483, 514425, 514 2, 51425211, 424 941, 435375
Abstract:
The present invention provides polymeric conjugates containing positively charged moieties. Methods of making the polymeric delivery systems and methods of treating mammals using the same are also disclosed.

Polymeric Linkers Containing Pyridyl Disulfide Moieties

US Patent:
2010020, Aug 12, 2010
Filed:
Sep 15, 2007
Appl. No.:
12/674006
Inventors:
Hong Zhao - Edison NJ, US
Prasanna Reddy - Somerset NJ, US
Jing Xia - Warren NJ, US
Assignee:
ENZON PHARMACEUTICALS, INC. - Bridgewater NJ
International Classification:
A61K 39/44
C07D 213/71
A61K 31/44
C07K 16/18
C07H 21/00
A61K 31/713
C07K 5/08
A61K 38/06
C07K 14/00
A61K 38/16
C07K 7/00
A61K 38/04
C07K 2/00
A61P 35/00
C12N 9/96
US Classification:
4241801, 546294, 514345, 5303919, 536 231, 514 44 R, 530331, 514 18, 530350, 514 12, 530327, 514 15, 530300, 435188
Abstract:
The present invention provides polymeric linkers containing pyridyl disulfide moieties. Methods of making the polymeric linkers and methods of making conjugates using the same are also disclosed.

Releasable Conjugates For Nucleic Acids Delivery Systems

US Patent:
2011023, Sep 22, 2011
Filed:
Nov 17, 2009
Appl. No.:
13/129705
Inventors:
Hong Zhao - Edison NJ, US
Jing Xia - Warren NJ, US
Prasanna Reddy - Somerset NJ, US
Assignee:
ENZON PHARMACEUTICALS, INC. - Bridgewater NJ
International Classification:
A61K 38/14
C12N 5/00
C07K 9/00
A61P 35/00
US Classification:
514 193, 435375, 530322
Abstract:
The present invention is directed to nucleic acids delivery systems and methods of modulating an expression of a target gene using the same. In particular, the invention relates to nucleic acids conjugates containing an endosomal release-promoting moiety. The nucleic acids conjugates further contain a nuclear localization signal moiety, and/or a cell targeting moiety.

Polymeric Conjugates Of Aromatic Amine Containing Compounds Including Releasable Urea Linker

US Patent:
2012028, Nov 15, 2012
Filed:
Dec 30, 2010
Appl. No.:
13/520120
Inventors:
Hong Zhao - Edison NJ, US
Dechun Wu - Bridgewater NJ, US
Snehlata Tripathi - Edison NJ, US
Jing Xia - Warren NJ, US
Assignee:
ENZON PHARMACEUTICALS, INC. - Piscataway NJ
International Classification:
C07D 403/14
A61K 31/404
A61P 35/00
C07D 403/06
US Classification:
514414, 548468, 548460
Abstract:
The present invention relates to releasable urea linker systems involving amine-containing chemical compounds and biologically active agents. In particular, the present invention relates to reversibly releasable linkers based on intramolecular cyclization-assisted releasable urea linkages to aromatic amine-containing compounds. The present invention also relates to polymeric conjugates of indolinone-based tyrosine kinase inhibitors.

Polymeric Conjugates Of Adenine Nucleoside Analogs

US Patent:
2013001, Jan 17, 2013
Filed:
Apr 15, 2011
Appl. No.:
13/637297
Inventors:
Hong Zhao - Edison NJ, US
Jing Xia - Warren NJ, US
Assignee:
ENZON PHARMACEUTICALS, INC. - Piscataway NJ
International Classification:
A61K 31/7064
A61P 31/12
C07H 19/16
A61P 35/00
A61K 31/7076
C07H 19/23
US Classification:
514 46, 514 49, 536 253, 536 272, 536 2721
Abstract:
The present invention relates to polymeric conjugates of adenine nucleoside analogs. In particular, the invention relates to multi-arm polyethylene glycol conjugates of adenine nucleoside analogs and use thereof. The present invention, more specifically, provides polymeric conjugates of toyocamycin and its derivatives. Furthermore, the present invention provides a method for preparing the polymeric conjugates of adenine nucleoside analogs and a method of using the same for treating a cancer, inhibiting the growth or proliferation of cancer cells, treating a viral infection, treating a disease or condition associated with abnormal expression of VEGF. Most polymeric conjugates of toyocamycin was stable in PBS but released toyocamycin in vivo to provided inhibition of cancer cell growth.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.